ReShape Lifesciences develops minimally invasive medical devices to treat obesity and metabolic diseasesRead more
ReShape Lifesciences's revenue is the ranked 14th among it's top 10 competitors. The top 10 competitors average 16.6M. Over the last two quarters, ReShape Lifesciences's revenue has grown by 7920.5%. Specifically, in Q2 2021's revenue was $3.5M; in Q3 2020, it was $ < 1M.